Do recent price falls mean Capitol Health Ltd and UXC Limited are in the bargain bin?

The Australian ALL ORDINARIES (INDEXASX: XAO) index plunged 2% on Friday to hit an eight-month low of 5,185 points. This is the cheapest the Australian sharemarket has been since early February and takes us back to where we were in late 2013.

The All Ordinaries and ASX 200 are now 8% from their late-August highs and high-flying small-cap stocks have been hit hard.

On Friday alone, two of my favourite small-caps on my watchlist plunged more than 7%! Capitol Health Ltd (ASX: CAJ) fell 7.2% and UXC Limited (ASX: UXC) fell 7.4%. These two promising small caps have now fallen 18% and 13% from their recent highs and are nearing my buy price. Here’s a little about the companies:

Capitol Health- Medical Accumulator

Capitol Health Ltd is a medical company with huge potential. Capitol is attempting to consolidate the non-hospital diagnostic imaging market in Australia. The company invests in Australian medical clinics that offer magnetic resonance imaging (MRI), CT scan, X-ray and ultrasound services. The company currently has around 50 clinics in Victoria and will hopefully start acquiring clinics in other states within the next 12 months.

At the latest price of 58 cents, Capitol still isn’t a screaming buy while it’s sitting on a trailing PE ratio of 34 and a forecast forward PE of around 27, but should it fall back into the 40’s I’d be very interested!

UXC- IT Specialists

Conversely, UXC Limited has pulled back to 82 cents from a recent high of 93 cents to trade on a trailing underlying PE ratio of just 17 and a forward PE of just 13. EPS fell significantly in the 2014 financial year due to one-off items but the company is well placed to grow substantially between now and 2016.

I’ve written about UXC before and still believe that it’s one of the best placed IT companies on the market. Execution is pivotal, but so far I’ve been impressed with management and believe that they will have no problem in meeting consensus estimates of a 33% jump in earnings this financial year.

In my view, these companies present a much better risk/return balance than some of the larger companies on the ASX, such as our big four banks.

You'd better take a look at this... especially if you own bank shares!

Warning: What you read in this newly updated investment report could surprise you! Be sure to get your FREE copy of "What Every Bank Shareholder Must Know" right now. This newly updated report is yours free when you click here now.

Motley Fool contributor Andrew Mudie does not own shares in any companies mentioned. You can find Andrew on Twitter @andrewmudie

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.